Ibrutinib-associated symptomatic intracerebral haemorrhage following IV thrombolysis for acute ischaemic stroke-Reference-Cited by-同舟云学术

Ibrutinib-associated symptomatic intracerebral haemorrhage following IV thrombolysis for acute ischaemic stroke

Published:2022-03-28 Issue:4 Volume:122 Page:1111-1113
ISSN:0300-9009
Container-title:Acta Neurologica Belgica
language:en
Short-container-title:Acta Neurol Belg

Author:

Madou Katrijn^ORCID,Carrette Sofie,Acou Marjan^ORCID,De Herdt Veerle^ORCID,Hemelsoet Dimitri^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13760-022-01935-y.pdf

Reference5 articles.

1. Wang M, Blum K, Martin P, Goy A, Auer R, Kahl B et al (2015) Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results. Blood 126:739–745

2. Shatzel J, Olson S, Tao D, McCarty O, Danilov A, DeLoughery T (2017) Ibrutinib-associated bleeding; pathogenesis, management, and risk reduction strategies. J Thromb Haemost 15:835–847

3. Quintavalla R, Lombardi M, Prandoni P, Manotti C, Tadonio I, Re F et al (2018) Increased dabigatran plasma concentration during Ibrutinib treatment: a case of cerebral hemorrhage and successful dabigatran reversal by idarucizumab. Aging Clin Exp Res 30:93–95

4. Allouchery M, Tomowiak C, Guidez S, Delwail V, Delaunay P, Lafay-Chebassier C et al (2021) Patterns of use and safety of ibrutinib in real-life practice. Br J Clin Pharmacol 87:895–904

5. Yaghi S, Willey J, Cucchiara B, Goldstein J, Gonzales N, Khatri P et al (2017) Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 48:e343–e361

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alteplase/aspirin/ibrutinib;Reactions Weekly;2022-08-13